Biotech Startups

Genomelink develops a platform that provides individuals with access to and management of their genomic data, leveraging advances in DNA sequencing technology. The company serves consumers seeking personal genetic information and operates in the genomics and digital health sector.

9 investors

Genomines uses biological systems to extract battery-grade nickel from low-grade soils, producing critical metals at lower cost and environmental impact than traditional mining. The company cultivates "metal farms" to create a more sustainable and decentralized supply chain for nickel used in batteries and electronics.

9 investors

Bristol Myers Squibb is a biopharmaceutical company that develops and delivers medicines across oncology, hematology, neuroscience, immunology, and cardiovascular disease areas. The company focuses on creating transformative treatments for patients in high-need therapeutic categories.

9 investors

Hoxton Farms grows cultivated fat, a biomanufactured ingredient for food companies to use in plant-based and alternative meat products. The company operates a production facility in London and partners with global food manufacturers to supply this ingredient.

9 investors

InnerPlant develops living sensor technology that enables farmers to detect plant stress in real-time, allowing targeted application of treatments to reduce chemical use and increase crop yields. The company serves agricultural producers seeking data-driven solutions for sustainable crop management.

9 investors

9 investors

Juvena Therapeutics develops biologics derived from human secreted proteins to treat aging-related diseases, using AI-enabled drug discovery to identify tissue-restorative therapeutics for muscle and metabolic disorders.

9 investors

Leiters Health is an FDA-registered 503B outsourcing facility that produces ready-to-administer compounded and repackaged sterile medications, including pre-filled syringes, IV bags, and ophthalmic solutions. It serves hospitals, health systems, surgery centers, clinics, and physician offices across the United States, helping address medication shortages and support pharmacy operations.

9 investors

Loyal develops therapeutics to help dogs live longer and healthier lives, focusing on canine aging research and longevity interventions for companion dogs.

9 investors

Medra builds robotic systems integrated with AI, computer vision, and natural language processing to automate data collection for life science research. The company serves biotech and academic research labs seeking high-precision, large-scale experimental data collection.

9 investors

Modern Meadow develops animal-free, bio-fabricated leather alternatives using synthetic biology and material science for the fashion, interiors, and automotive industries. Its flagship product, INNOVERA™, is engineered from plant-based proteins, biopolymers, and recycled materials to replicate leather performance while maintaining high renewable carbon content.

9 investors

Mosa Meat is a food technology company that produces cultivated beef by growing muscle cells from a small animal sample into real meat, aiming to make beef burgers without slaughtering animals. It positions its product as a lower-impact alternative for consumers and food-service partners.

9 investors

Octant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases. Using synthetic biology, high-throughput chemistry, and AI/ML, the company's Navigator platform studies how target proteins interact within living human cells to enable drug discovery for rare diseases and oncology.

9 investors

Helicons develops a peptide-based therapeutic platform designed to target intracellular proteins previously considered undruggable by combining the specificity of antibodies with the cell-penetrating properties of small molecules. The platform uses AI and simulation to engineer helical peptides with non-canonical amino acids for precision binding across a range of therapeutic applications.

9 investors

Parallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery. The company aims to accelerate pharmaceutical development and reduce clinical trial failure rates through human-first biological prediction models.

9 investors

Plantible Foods redesigns the food supply chain to advance health for people and the planet. The company operates in the foodtech and agtech sectors.

9 investors

ShiraTronics is a medical device company developing an implantable device to treat chronic migraine disease. It is a privately held company operating in the medical device and healthcare industry.

9 investors

Synthego develops CRISPR gene-editing and molecular diagnostics products, including custom CRISPR editors in mRNA or protein formats, base editors, and cell-free protein and RNA production systems. It serves researchers and cell and gene therapy developers in the biotechnology industry.

9 investors

SelfWrap develops bioabsorbable wrap materials for vascular grafts that conform to individual patient anatomy and are designed to be absorbed by the body, unlike alloy-based alternatives. The company is developing the product for coronary and peripheral bypass grafting applications.

9 investors

Verge Labs builds AI models trained on multimodal human patient data to predict drug targets and patient populations for clinical development, primarily in neuroscience and central nervous system (CNS) disease. The company applies frontier AI techniques to drug discovery for life sciences and pharmaceutical development.

9 investors

Verona Pharma develops treatments for chronic lung conditions. As of October 2025, it and its subsidiaries are part of Merck & Co., Inc.

9 investors

Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment. Its approach aims to achieve durable efficacy for cancer patients while avoiding the severe systemic side effects of conventional immuno-oncology agents.

9 investors

Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need. The company engineers therapeutic medicines designed to deliver clinically differentiated outcomes for cancer patients.

8 investors

Aleph Farms develops cultivated meat, growing beef steaks from cow cells using tissue engineering technology, and produced the world's first cultivated thin-cut and ribeye steaks. The company received the world's first regulatory approval for cultivated beef and markets its products under the Aleph Cuts brand.

8 investors